Study on the Effectiveness and Tolerability of Ofatumumab Compared to a Drug Combination for Patients with Newly Diagnosed Relapsing Multiple Sclerosis

Registered drugNo placebo

Study on the Effectiveness and Tolerability of Ofatumumab Compared to a Drug Combination for Patients with Newly Diagnosed Relapsing Multiple Sclerosis

Registered drugNo placebo

France

Participants:18–64 years
Substances:Dimethyl Fumarate

Contact Research Centre

Multiple sclerosis+4

Not recruiting

Study on Metformin for Delaying Progression in Non-Active Progressive Multiple Sclerosis Patients

Registered drug

Study on Metformin for Delaying Progression in Non-Active Progressive Multiple Sclerosis Patients

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Dimethyl Fumarate

Contact Research Centre

Friedreich's ataxia

Not recruiting

Study on the Effects of Dimethyl Fumarate for Patients with Friedreich's Ataxia

Registered drug

Study on the Effects of Dimethyl Fumarate for Patients with Friedreich's Ataxia

Registered drug

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Dimethyl Fumarate

Contact Research Centre

Secondary progressive multiple sclerosis

Not recruiting

Study on Stopping Disease-Modifying Therapies in Inactive Secondary Progressive Multiple Sclerosis Patients Over 50 Using Glatiramer Acetate and Drug Combination

Registered drugNo placebo

Study on Stopping Disease-Modifying Therapies in Inactive Secondary Progressive Multiple Sclerosis Patients Over 50 Using Glatiramer Acetate and Drug Combination

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azathioprine

Contact Research Centre

Find therapies in clinical trials near you

13 trials match your criteria

Relapsing-remitting multiple sclerosis

Study on Anti-CD20 Therapy and Drug Combination for Patients with Relapsing-Remitting Multiple Sclerosis

Multiple sclerosis

Study on Stopping Dimethyl Fumarate and Drug Combination in Patients Aged 55+ with Inactive Relapsing-Remitting Multiple Sclerosis

Dementia Alzheimer's type

Study on Dimethyl Fumarate for Patients with Mild Cognitive Impairment and Alzheimer's Disease

Plasma cell myeloma

Study on the Safety and Effectiveness of AZD0305 Alone and with Other Cancer Drugs for Adults with Relapsed or Refractory Multiple Myeloma

Macular degeneration

Study of dimethyl fumarate to slow the progression of geographic atrophy in patients with age-related macular degeneration (dry form)

Neurodegenerative disorder

Study of dimethyl fumarate safety and efficacy in patients with Neurodegeneration with Brain Iron Accumulation (NBIA), including PKAN and MPAN

Adrenoleukodystrophy

Study on the Effects of Dimethyl Fumarate for Patients with Adrenomyeloneuropathy

Myelofibrosis

Study Comparing Fedratinib with Drug Combination for Myelofibrosis in Patients Previously Treated with Ruxolitinib

Multiple sclerosis relapse

Study on the Effectiveness and Tolerability of Ofatumumab Compared to a Drug Combination for Patients with Newly Diagnosed Relapsing Multiple Sclerosis

Multiple sclerosis+4

Study on Metformin for Delaying Progression in Non-Active Progressive Multiple Sclerosis Patients

Friedreich's ataxia

Study on the Effects of Dimethyl Fumarate for Patients with Friedreich's Ataxia

Secondary progressive multiple sclerosis

Study on Stopping Disease-Modifying Therapies in Inactive Secondary Progressive Multiple Sclerosis Patients Over 50 Using Glatiramer Acetate and Drug Combination

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.